Alignment Healthcare, Inc. — Director's Dealing 2021

Apr 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2021-04-06

Reporting Person: WARBURG PINCUS LLC (Director, 10% Owner)
Reporting Person: Warburg Pincus Private Equity XII, L.P. (Director, 10% Owner)
Reporting Person: Warburg Pincus Private Equity XII-B, L.P. (Director, 10% Owner)
Reporting Person: Warburg Pincus Private Equity XII-D, L.P. (Director, 10% Owner)
Reporting Person: Warburg Pincus Private Equity XII-E, L.P. (Director, 10% Owner)
Reporting Person: WP XII Partners, L.P. (Director, 10% Owner)
Reporting Person: Warburg Pincus XII Partners, L.P. (Director, 10% Owner)
Reporting Person: WARBURG PINCUS XII, L.P. (Director, 10% Owner)
Reporting Person: WP Global LLC (Director, 10% Owner)
Reporting Person: Warburg Pincus Partners II, L.P. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-06	Common Stock, par value $0.001 per share	S	716624	$16.83	Disposed	24802721	Indirect

Footnotes

F1: Represents 461,584 shares of Common Stock sold by Warburg Pincus Private Equity XII, L.P., a Delaware limited partnership ("WP XII"), 92,610 shares of Common Stock sold by Warburg Pincus Private Equity XII-B, L.P., a Delaware limited partnership ("WP XII-B"), 13,322 shares of Common Stock sold by Warburg Pincus Private Equity XII-D, L.P., a Delaware limited partnership ("WP XII-D"), and 76,034 share of Common Stock sold by Warburg Pincus Private Equity XII-E, L.P., a Delaware limited partnership ("WP XII-E"), 24,903 shares of Common Stock sold by WP XII Partners, L.P., a Delaware limited partnership ("WP XII Partners"), 48,171 shares of Common Stock sold by Warburg Pincus XII Partners, L.P., a Delaware limited partnership ("Warburg Pincus XII Partners") pursuant the partial exercise by the underwriters of their over-allotment option (the "Transaction") after the closing of Alignment Healthcare Inc.'s initial public offering, at a price of $16.83 (net of underwriting discount).

F2: Reflects securities held directly by WP XII, WP XII-B, WP XII-D, WP XII-E, WP XII Partners, and Warburg Pincus XII Partners (together with WP XII, WP XII-B, WP XII-D, WP XII-E, and WP XII Partners, the "WP XII Funds") following the closing of the Transaction. Warburg Pincus XII, L.P., a Delaware limited partnership ("WP XII GP"), is the general partner of the WP XII Funds. WP Global LLC, a Delaware limited liability company ("WP Global"), is the general partner of WP XII GP. Warburg Pincus Partners II, L.P., a Delaware limited partnership ("WPP II"), is the managing member of WP Global. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WPP II.

F3: (Continued Form Footnote 2 ) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WPP GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is a registered investment adviser and the manager of the WP XII Funds. Investment and voting decisions with respect to the shares held by the WP XII Funds are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the shares.